Cost-Effectiveness Analysis of Triple Therapy with Budesonide/ Glycopyrronium/ Formoterol Fumarate versus Dual Therapy in Patients with Chronic Obstructive Pulmonary Disease in Spain

Cost-Effectiveness Analysis of Triple Therapy with Budesonide/ Glycopyrronium/ Formoterol Fumarate versus Dual Therapy in Patients with Chronic Obstructive Pulmonary Disease in Spain

Juan Antonio Trigueros,1 Noé Garin,2 Adolfo Baloira,3 Susana Aceituno,4 Ana Calvo,4 Miriam Prades,4 Carolina Touron,5 Anisia Martínez,5 Covadonga Torres5 1Health Center Menasalbas, Castilla-La Mancha Health Service, Toledo, Spain; 2Pharmacy Department, Hospital of the Santa Creu i Sant Pau, Barcelon...

Full description

Bibliographic Details
Main Authors: Trigueros JA, Garin N, Baloira A, Aceituno S, Calvo A, Prades M, Touron C, Martínez A, Torres C
Format: Article
Language:English
Published: Dove Medical Press 2022-11-01
Series:International Journal of COPD
Subjects:
copd
economic evaluation
exacerbation
inhaled bronchodilator
inhaled corticosteroid
single-inhaler triple therapy;
Online Access:https://www.dovepress.com/cost-effectiveness-analysis-of-triple-therapy-with-budesonide-glycopyr-peer-reviewed-fulltext-article-COPD

Internet

https://www.dovepress.com/cost-effectiveness-analysis-of-triple-therapy-with-budesonide-glycopyr-peer-reviewed-fulltext-article-COPD

Similar Items